Summary
NF- K B is a designation originally referring to a DNA-binding activity that bound the K B enhancer of immunoglobulin K light chain and stimulated transcription. The proteins responsible for this activity have since been cloned and studied extensively by immunologists, structural biochemists, and cell biologists. Only recently have neurobiologists turned their attention to NF- K B to study its role in the nervous system. Predictable roles for NF- K B in the regulation of glial cytokines have been confirmed. Less obvious roles have been suggested for NF- K B in processes peculiar to neurons, such as synaptic plasticity. Its participation in inflammation and its induction by toxic stimuli such as tumor necrosis factor (TNF) led to the common interpretation of NF- K B as a pathogenic factor. An alternative interpretation, that NF- K B is involved in compensatory responses to pathogens, was supported by our demonstration that some neuroprotective factors can activate NF- K B or a similar activity in neurons. At least one of these factors - secreted β-amyloid precursor protein (sAPP) - can also induce NF- K B and inflammatory reactions in microglia, the phagocytic inflammatory cells of the central nervous system. This fact makes sAPP a factor with both beneficial and harmful effects on neuronal health. This “double-edged” phenomenon and the factors that influence the balance of sAPP’s effects are discussed herein.
This is a preview of subscription content, log in via an institution.
Buying options
Tax calculation will be finalised at checkout
Purchases are for personal use only
Learn about institutional subscriptionsPreview
Unable to display preview. Download preview PDF.
References
Anderson JP, Esch FS, Keim PS, Sambamurti K, Lieberburg I, Robakis NK (1991) Exact cleavage site of Alzheimer amyloid precursor in neuronal PC-12 cells. Neurosci Lett 128:126–128
Barger SW (1997) Tumor necrosis factor: the good, the bad, and the umbra. In: Mattson MP (ed) Neuroprotective Signal Transduction. Humana, Totawa, NJ, pp. 163–183
Barger SW, Mattson MP (1996a) Induction of neuroprotective K B-dependent transcription by secreted form of the Alzheimer’s β-amyloid precusor. Mol Brain Res 40:116–126
Barger SW, Mattson MP (1996b) Participation of gene expression in the protection against amyloid β-peptide toxicity by the β-amyloid precursor protein. Ann NY Acad Sci 777:303–308
Barger SW, Mattson MP (1997) Isoform-specific modulation by apolipoprotein E of the activities of secreted β-amyloid precursor protein. J Neurochem 69:60–66
Barger SW, Harmon AD (1997) Microglial activation by secreted Alzheimer amyloid precursor protein and modulation by apolipoprotein E. Nature 388:878–881
Barger SW, Fiscus RR, Ruth P, Hofmann F, Mattson MP (1995a) The role of cyclic GMP in the regulation of neuronal calcium and survival by secreted forms of β-amyloid precursor. J Neurochem 64:2087–2096
Barger SW, Horster D, Furukawa K, Goodman Y, Kriegelstein J, Mattson MP (1995b) Tumor necrosis factors a and β protect neurons against amyloid β-peptide toxicity: Evidence for involvement of a K B-binding factor and attenuation of peroxide and Ca2+ accumulation. Proc Natl Acad Sci USA 92:9328–9332
Breitner JCS (1996) The role of anti-inflammatory drugs in the prevention and treatment of Alzheimer’s disease. Annu Rev Med 47:401–411
Buxbaum JD, Greengard P (1996) Regulation of APP processing by intra- and intercellular signals. Ann NY Acad Sci 777:327–331
Buxbaum JD, Oishi M, Chen HI, Pinkas-Kramarski R, Jaffe EA, Gandy SB, Greengard P (1992) Cholinergic agonists and interleukin 1 regulate processing and secretion of the Alzheimer β/A4 amyloid protein precursor. Proc Natl Acad Sci USA 89:10075–10078
Colton C, Wilt S, Gilbert D, Chernyshev O, Snell J, Dubois-Dalcq M (1996) Species differences in the generation of reactive oxygen species by microglia. Mol Chem Neuropathol 28:15–20
Corder EH, Saunders AM, Risch NJ, Strittmatter WJ, Schmechel DE, Gaskell PCJ, Rimmler JB, Locke PA, Conneally PM, Schmader KE (1994) Protective effect of apolipoprotein B type 2 allele for late onset Alzheimer disease. Nat Genet 7:180–184
Cras P, Kawai M, Siedlak S, Mulvihill P, Gambetti P, Lowery D, Gonzalez-DeWhitt P, Greenberg B, Perry G (1990) Neuronal and microglial involvement in β-amyloid protein deposition in Alzheimer’s disease. Am J Pathol 137:241–246
Cras P, Kawai M, Lowery D, Gonzaiez-DeWhitt P, Greenberg B, Perry G (1991) Senile plaque neurites in Alzheimer disease accumulate amyloid precursor protein. Proc Natl Acad Sci USA 88:7552–7556
Desterro JMP, Rodriguez MS, Hay RT (1998) SUMO-1 modification of I K Ba inhibits NF-KB activation. Mol Cell 2:233–239
Egensperger R, Kosel S, vonEitzen U, Graeber MB (1998) Microglial activation in Alzheimer disease: Association with APOE genotype. Brain Pathol 8:439–447
Esch FS, Kiem PS, Beattie BC, Blacher RW, Culwell AR, Olsterdorf T, McClure D, Ward PJ (1990) Cleavage of amyloid β peptide during constitutive processing of its precursor. Science 248:1122–1124
Furukawa K, Barger SW, Blalock EM, Mattson MP (1996a) Activation of potassium channels and suppression of neuronal activity by secreted β-amyloid precursor protein. Nature 379:74–78
Furukawa K, Sopher BL, Rydel RE, Begley JG, Pham DG, Martin GM, Fox M, Mattson MP (1996b) Increased activity-regulating and neuroprotective efficacy of a-secretase-derived secreted amyloid precursor protein conferred by a c-terminal heparin-binding domain. J Neurochem 67: 1882–1896
Giulian D, Yu J, Li X, Tom D, Li J, Wendt E, Lin SN, Schwarcz R, Noonan C (1996) Study of receptor-mediated neurotoxins released by HIV-1-infected mononuclear phagocytes found in human brain. J Neurosci 16:3139–3153
Goldgaber D, Lerman MI, McBride OW, Saffiotti U, Gajdusek DC (1987) Characterization and chromosomal localization of a cDNA encoding brain amyioid of Alzheimer’s disease. Science 235:877–880
Goldgaber D, Harris HW, Hla T, Maciag T, Donnelly RJ, Jacobsen JS, Vitek MP, Gajdusek DC (1989) Interleukin-1 regulates synthesis of amyloid β-protein precursor mRNA in human endothelial cells. Proc Natl Acad Sci USA 86:7606–7610
Goodman Y, Mattson MP (1994) Secreted forms of ft amyloid precursor protein protect hippocampal neurons against β-peptide toxicity and oxidative injury. Exp Neurol 128:1–12
Goodman Y, Mattson MP (1996) Ceramide protects hippocampal neurons against excitotoxic and oxidative insults, and amyloid β-peptide toxicity. J Neurochem 66:869–872
Greenberg SM, Koo EH, Selkoe DJ, Qiu WQ, Kosik KS (1994) Secreted β-amyloid precursor protein stimulates mitogen-activated protein kinase and enhances tau phosphorylation. Proc Natl Acad Sci USA 91:7104–7108
Griffin WS, Sheng JG, Roberts GW, Mrak RE (1995) Interleukin-1 expression in different plaque types in Alzheimer’s disease: significance in plaque evolution. J Neuropathol Exp Neurol 54:276–281
Griffin WST, Stanley LC, Ling C, White L, MacLeod V, Perrot LJ, White CLI, Araoz C (1989) Brain interleukin 1 and S-100 immunoreactivity are elevated in Down syndrome and Alzheimer disease. Proc Natl Acad Sci USA 86:7611–7615
Griffin WS, Sheng JG, Royston MC, Gentleman SM, McKenzie JE, Graham DI, Roberts GW, Mrak RE (1998) Glial-neuronal interactions in Alzheimer’s disease: the potential role of a ’cytokine cycle’ in disease progression. Brain Pathol 8:65–72
Grilli M, Goffi F, Memo M, Spano P (1996) Interleukin-1 β and glutamate activate the NF- K B/Rel binding site from the regulatory region of the amyloid precursor protein gene in primary neuronal cultures. J Biol Chem 271:15002–15007
Grisham MB, Johnson GG, Lancaster JR, Jr. (1996) Quantitation of nitrate and nitrite in extracellular fluids. Methods Enzymol 268:237–246
Guerrini L, Blasi F, Denis-Donini S (1994) Activation of NF K B upon glutamate stimulation in cultured mouse cerebellar granule cells. Soc Neurosci Abstr 20:1510
Guerrini L, Blasi F, Denis-Donini S (1995) Synaptic activation of NF- K B by glutamate in cerebellar granule neurons in vitro. Proc Natl Acad Sci USA 92:9077–9081
Haass C, Lemere CA, Capell A, Citron M, Seubert P, Schenk D, Lannfelt L, Selkoe DJ (1995) The Swedish mutation causes early-onset Alzheimer’s disease by β-secretase cleavage within the secretory pathway. Nature Med 1:1291–1296
Hardy J (1997) Amyloid, the presenilins and Alzheimer’s disease. Trends Neurosci 20:154–159
Hass S, Fresser F, Kochl S, Beyreuther K, Utermann G, Baier G (1998) Physical interaction of ApoE with amyloid precursor protein independent of the amyloid Aβ region in vitro. J Biol Chem 273:13892–13897.
Ishida A, Furukawa K, Keller JN, Mattson MP (1997) Secreted form of β-amyloid precursor protein shifts the frequency dependency for induction of LTD, and enhances LTP in hippocampal slices. Neuroreport 8:2133–2137
Jin LW, Ninomiya H, Roch JM, Schubert D, Masliah E, Otero DA, Saitoh T (1994) Peptides containing the RERMS sequence of amyloid β/A4 protein precursor bind cell surface and promote neurite extension. J Neurosci 14:5461–5470
Joachim C, Games D, Morris J, Ward P, Frenkel D, Selkoe D (1991) Antibodies to non-p regions of the β-amyioid precursor protein detect a subset of senile plaques. Am J Pathol 138:373–384
Kaltschmidt C, Kaltschmidt B, Baeuerle PA (1995) Stimulation of ionotropic glutamate receptors activates transcription factor NF- K B in primary neurons. Proc Natl Acad Sci USA 92:9618–9622
Li HL, Roch JM, Sundsmo M, Otero D, Sisodia S, Thomas R, Saitoh T (1997) Defective neurite extension is caused by a mutation in amyloid β/A4 (Ap) protein precursor found in familial Alzheimer’s disease J Neurobiol 32:469–480
Lipton SA (1994) AIDS-related dementia and calcium homeostasis. Ann N YAcad Sci 747:205–224
Lipton SA, Choi YB, Pan ZH, Lei SZ, Chen HS, Sucher NJ, Loscalzo J, Singel DJ, Stamler JS (1993) A redox-based mechanism for the neuroprotective and neurodestructive effects of nitric oxide and related nitroso-compounds. Nature 364:626–632
Mao X, Barger SW (1998) Neuroprotection by dehydroepiandrosterone-sulfate: involvement of an NF K B-like factor. NeuroReport 9:759–763
Mao X, Moerman AM, Lucas MM, Barger SW (1999) Inhibition of a neuronal K B-binding factor by glutamate. J Neurochem (in press)
Mattson MP, Barger SW (1993) Roles for calcium signalling in structural plasticity and pathology in the hippocampal system. Hippocampus 3:73–87
Mattson MP, Cheng B, Culwell AR, Esch FS, Lieberburg 1, Rydel RE (1993) Evidence for excitoprotective and intraneuronal calcium-regulating roles for secreted forms of the β-amyloid precursor protein. Neuron 10:243–254
Mattson MP, Cheng B, Baldwin SA, Smith-Swintosky VL, Keller J, Geddes JW, Scheff SW, Christakos S (1995) Brain injury and tumor necrosis factors induce calbindin D-28k in astrocytes: evidence for a cytoprotective response. J Neurosci Res 42:357–370
Mattson MP, Goodman Y, Luo H, Fu W, Furukawa K (1997) Activation of NF- K B protects hippocampal neurons against oxidative stress-induced apoptosis: evidence for induction of manganese superoxide dismutase and suppression of peroxynitrite production and protein tyrosine nitration. J Neurosci Res 49:681–697
Meda L, Cassatella MA, Szendrei GI, Otvos L, Jr., Baron P, Villalba M, Ferran D, Rossi F (1995) Activation of microglial cells by β-amyloid protein and interferon-y. Nature 374:647–650
Meier TJ, Ho DY, Park TS, Sapolsky RM (1998) Gene transfer of calbindin D28k cDNA via herpes simplex virus amplicon vector decreases cytoplasmic calcium ion response and enhances neuronal survival following glutamatergic challenge but not following cyanide. J Neurochem 71: 1013–1023
Meyer MR, Tschanz JT, Norton MC, Welsh-Bohmer KA, Steffens DC, Wyse BW, Breitner JC (1998) APOE genotype predicts when-not whether-one is predisposed to develop Alzheimer disease. Nat Genet 19:321–322
Moerman AM, Mao X, Lucas MM, Barger SW (1999) Characterization of a neuronal K B-binding factor distinct from NF- K B. Mol Brain Res 67:303–315
Mucke L, Masliah E, Johnson WB, Ruppe MD, Alford M, Rockenstein EM, Forss-Petter S, Pietropaolo M, Mallory M, Abraham CR (1994) Synaptotrophic effects of human amyloid β protein precursors in the cortex of transgenic mice. Brain Res 666:151–167
Murray CA, Lynch MA (1998) Evidence that increased hippocampal expression of the cytokine interleukin-1β is a common trigger for age- and stress-induced impairments in long-term potentiation. J Neurosci 18:2974–2981
Nasman B, Olsson T, Backstrom T, Eriksson S, Grankvist K, Vutanen M, Bucht G (1991) Serum dehydroepiandrosterone sulfate in Alzheimer’s disease and in multi-infarct dementia. Biol Psych 30:684–690
Nitsch RM, Slack BE, Wurtman RJ, Growdon JH (1992) Release of Alzheimer amyloid precursor derivatives stimulated by activation of muscarinic acetylcholine receptors. Science 258:304–307
Palombella VJ, Rando OJ, Goldberg AL, Maniatis T (1994) The ubiquitin-proteasome pathway is required for processing the NF- K Bl precursor protein and the activation of NF- K B. Cell 78:773–785
Robakis NK, Ramakrishna N, Wolfe G, Wisniewski HM (1987) Molecular cloning and characterization of a cDNA encoding the cerebrovascular and the neuritic plaque amyloid peptides. Proc Natl Acad Sci USA 84:4190–4194
Roch JM, Masliah E, Roch-Levecq AC, Sundsmo MP, Otero DA, Veinbergs I, Saitoh T (1994) Increase of synaptic density and memory retention by a peptide representing the trophic domain of the amyloid β/A4 protein precursor. Proc Natl Acad Sci USA 91:7450–7454
Roses AD (1997) Apolipoprotein E, a gene with complex biological interactions in the aging brain. Neurobiol Dis 4:170–185
Saitoh T, Sundsmo M, Roch J-M, Ximura M, Cole G, Schubert D, Oltersdorf T, Schenk DB (1989) Secreted form of amyloid β protein precursor is involved in the growth regulation of fibroblasts. Cell 58:615–622.
Shoji M, Hirai S, Yamaguchi H, Harigaya Y, Kawarabayashi T (1990) Amyloid β-protein precursor accumulates in dystrophic neurites of senile plaques in Alzheimer-type dementia. Brain Res 512:164–168
Small DH, Nurcombe V, Reed G, Clarris H, Moir R, Beyreuther K, Masters CL (1994) A heparinbinding domain in the amyloid protein precursor of Alzheimer’s disease is involved in the regulation of neurite outgrowth. J Neurosci 14:2117–2127
Tanzi RE, Gusella JF, Watkins PC, Bruns GA, St George-Hyslop P, VanKeuren ML, Patterson D, Pagan S, Kurnit DM, Neve RL (1987) Amyloid P protein gene: cDNA, mRNA distribution, and genetic linkage near the Alzheimer locus. Science 235:880–884
VanNostrand WE, Cunningham DD (1987) Purification of protease nexin II from human fibroblasts. J Biol Chem 262:8508–8514
Wang CY, Mayo MW, Korneluk RG, Goeddel DV, Baldwin AS, Jr. (1998) NF- K B-antiapoptosis: induction of TRAF1 and TRAF2 and c-IAPl and C-IAP2 to suppress caspase-8 activation. Science 281:1680–1683
Wu MX, Ao Z, Prasad KV, Wu R, Schlossman SF (1998) IEX-1L, an apoptosis inhibitor involved in NF- K B-mediated cell survival. Science 281:998–1001
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2000 Springer-Verlag Berlin Heidelberg
About this paper
Cite this paper
Barger, S.W., Mao, X., Moerman, A.M., Ranganathan, A. (2000). Mechanistic and Metaphorical Connections Between NF-KB and the Secreted Alzheimer’s β-Amyloid Precursor Protein. In: Patterson, P., Kordon, C., Christen, Y. (eds) Neuro-Immune Interactions in Neurologic and Psychiatric Disorders. Research and Perspectives in Neurosciences. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-642-59643-8_6
Download citation
DOI: https://doi.org/10.1007/978-3-642-59643-8_6
Publisher Name: Springer, Berlin, Heidelberg
Print ISBN: 978-3-642-64065-0
Online ISBN: 978-3-642-59643-8
eBook Packages: Springer Book Archive